Literature DB >> 9561312

Treatment outcome of personality disorders.

C A Sanislow1, T H McGlashan.   

Abstract

OBJECTIVE: To review the treatment outcome of personality disorders.
METHOD: A literature search of studies pertaining to personality disorder and outcome was conducted, and studies that focused primarily on Axis II were retained. Of these, naturalistic outcome studies were distinguished from those that addressed treatment outcome specifically. The treatment outcome studies were examined in terms of type of treatment intervention, dependent variables, and outcome.
RESULTS: Contrary to contemporary assumptions about Axis II, a substantial number of treatment outcome studies were identified. Trends in the assumptions underlying psychosocial and pharmacologic approaches were identified on the basis of dependent variables.
CONCLUSION: There is evidence that effective treatments exist to alleviate symptoms and reduce symptomatic behaviours that accompany personality disorders. What these results hold for the idea of remission from personality disorder is considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9561312     DOI: 10.1177/070674379804300302

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  14 in total

Review 1.  Psychotherapy of personality disorders.

Authors:  W E Piper; J S Ogrodniczuk
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

Review 2.  The effectiveness of cognitive behavioral therapy for personality disorders.

Authors:  Alexis K Matusiewicz; Christopher J Hopwood; Annie N Banducci; C W Lejuez
Journal:  Psychiatr Clin North Am       Date:  2010-09

3.  Personality disorder in psychiatric practice.

Authors:  Peter Tyrer; Erik Simonsen
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

4.  Exploratory factor analysis of borderline personality disorder criteria in monolingual Hispanic outpatients with substance use disorders.

Authors:  Daniel F Becker; Luis Miguel Añez; Manuel Paris; Carlos M Grilo
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

5.  The relation between antisocial and borderline personality symptoms and early maladaptive schemas in a treatment seeking sample of male substance users.

Authors:  Ryan C Shorey; Scott Anderson; Gregory L Stuart
Journal:  Clin Psychol Psychother       Date:  2013-05-06

6.  Remnants and changes in facial emotion processing in women with remitted borderline personality disorder: an EEG study.

Authors:  Isabella Schneider; Katja Bertsch; Natalie A Izurieta Hidalgo; Laura E Müller; Christian Schmahl; Sabine C Herpertz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-09-27       Impact factor: 5.270

Review 7.  Current issues in the assessment of personality disorders.

Authors:  Thomas A Widiger; Kaylynn Chaynes
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

8.  Two-year prevalence and stability of individual DSM-IV criteria for schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders: toward a hybrid model of axis II disorders.

Authors:  Thomas H McGlashan; Carlos M Grilo; Charles A Sanislow; Elizabeth Ralevski; Leslie C Morey; John G Gunderson; Andrew E Skodol; M Tracie Shea; Mary C Zanarini; Donna Bender; Robert L Stout; Shirley Yen; Maria Pagano
Journal:  Am J Psychiatry       Date:  2005-05       Impact factor: 18.112

9.  Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.

Authors:  Carlos M Grilo; Charles A Sanislow; John G Gunderson; Maria E Pagano; Shirley Yen; Mary C Zanarini; M Tracie Shea; Andrew E Skodol; Robert L Stout; Leslie C Morey; Thomas H McGlashan
Journal:  J Consult Clin Psychol       Date:  2004-10

10.  Age and remission of personality pathology in the psychotic disorders compared to mood and/or anxiety disorders.

Authors:  Tianhong Zhang; Mary-Jo D Good; Byron J Good; Annabelle Chow; Lanlan Wang; Yunfei Dai; Zeping Xiao
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.